David R. Raleigh

11.1k total citations · 1 hit paper
156 papers, 4.4k citations indexed

About

David R. Raleigh is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, David R. Raleigh has authored 156 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 55 papers in Molecular Biology and 54 papers in Genetics. Recurrent topics in David R. Raleigh's work include Meningioma and schwannoma management (68 papers), Glioma Diagnosis and Treatment (54 papers) and Neurofibromatosis and Schwannoma Cases (23 papers). David R. Raleigh is often cited by papers focused on Meningioma and schwannoma management (68 papers), Glioma Diagnosis and Treatment (54 papers) and Neurofibromatosis and Schwannoma Cases (23 papers). David R. Raleigh collaborates with scholars based in United States, Germany and Canada. David R. Raleigh's co-authors include Jerrold R. Turner, Le Shen, Christopher R. Weber, Dan Yu, Yingmin Wang, Amanda M. Marchiando, Jeremy F. Reiter, Steve Braunstein, Stephen T. Magill and Manish K. Aghi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David R. Raleigh

141 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tight Junction Pore and Leak Pathways: A Dynamic Duo

2011 678 citations Le Shen, Christopher R. Weber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David R. Raleigh United States	31	1.9k	1.2k	993	747	692	156	4.4k
Oded Foreman United States	38	2.6k 1.3×	1.1k 0.9×	767 0.8×	456 0.6×	369 0.5×	99	6.3k
Nicolas Cagnard France	35	2.3k 1.2×	946 0.8×	624 0.6×	409 0.5×	661 1.0×	83	7.2k
Peter N. Monk United Kingdom	44	2.1k 1.1×	518 0.4×	990 1.0×	641 0.9×	255 0.4×	127	6.2k
Piet Stinissen Belgium	48	1.4k 0.7×	971 0.8×	458 0.5×	316 0.4×	239 0.3×	162	6.7k
George Kassiotis United Kingdom	38	2.1k 1.1×	885 0.7×	512 0.5×	576 0.8×	119 0.2×	100	6.3k
Rimpei Morita Japan	39	1.7k 0.9×	394 0.3×	696 0.7×	192 0.3×	476 0.7×	84	6.7k
Tatsuro Ishibashi Japan	49	3.7k 1.9×	741 0.6×	505 0.5×	130 0.2×	254 0.4×	235	9.7k
Per Anderson Spain	31	1.4k 0.7×	370 0.3×	353 0.4×	914 1.2×	538 0.8×	69	4.0k
H. Terence Cook United Kingdom	48	2.2k 1.1×	299 0.2×	454 0.5×	802 1.1×	577 0.8×	122	9.6k
M. Elizabeth Fini United States	47	2.6k 1.3×	744 0.6×	621 0.6×	143 0.2×	289 0.4×	115	8.5k

Countries citing papers authored by David R. Raleigh

Since Specialization

Citations

This map shows the geographic impact of David R. Raleigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Raleigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Raleigh more than expected).

Fields of papers citing papers by David R. Raleigh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Raleigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Raleigh. The network helps show where David R. Raleigh may publish in the future.

Co-authorship network of co-authors of David R. Raleigh

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Raleigh. A scholar is included among the top collaborators of David R. Raleigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Raleigh. David R. Raleigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boreta, Lauren & David R. Raleigh. (2025). Proton Craniospinal Irradiation for Leptomeningeal Metastases. JAMA Oncology. 11(11). 1301–1301.

Nguyen, Minh, Kanish Mirchia, William Chen, et al.. (2024). Response to immune checkpoint inhibition in a meningioma with DNA mismatch repair deficiency. Neuro-Oncology Advances. 6(1). vdae092–vdae092. 2 indexed citations

Wang, Su, Abdul Wali Khan, Stephen T. Magill, et al.. (2024). Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data. Journal of Neuro-Oncology. 168(3). 515–524. 1 indexed citations

Bisignano, Paola, David R. Raleigh, Gabriel B. Loeb, et al.. (2024). Cilia-enriched oxysterol 7β,27-DHC is required for polycystin ion channel activation. Nature Communications. 15(1). 6468–6468. 7 indexed citations

Eaton, Charlotte, Siyuan Liu, Paola Bisignano, et al.. (2024). MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features. Nature Communications. 15(1). 7873–7873. 2 indexed citations

Miao, Bo, Yogesh Yadav, Jurriaan H. de Groot, et al.. (2024). P10.06.A AGENT-BASED MODELING FOR PATIENT-CENTERED CLINICAL DECISION SUPPORT IN NEURO-ONCOLOGY. Neuro-Oncology. 26(Supplement_5). v56–v56.

Nandoliya, Khizar R., Constantine L. Karras, Pouya Jamshidi, et al.. (2023). Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. Cancers. 15(13). 3374–3374. 2 indexed citations

Lin, Kevin, Laine Goudy, Joshua J. Pak, et al.. (2023). CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). S42–S43. 2 indexed citations

Garcia, Joseph H., Saket Jain, Kayla J. Wolf, et al.. (2023). Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations. Journal of Clinical Investigation. 134(3). 13 indexed citations

10.

Lo, Megan, Amnon Sharir, Michael Paul, et al.. (2022). CNPY4 inhibits the Hedgehog pathway by modulating membrane sterol lipids. Nature Communications. 13(1). 2407–2407. 6 indexed citations

11.

Daggubati, Vikas, Abrar Choudhury, Alexis Leigh Krup, et al.. (2021). Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models. Journal of Clinical Investigation. 131(6). 16 indexed citations

12.

Lucas, Calixto‐Hope G., Harish N. Vasudevan, William Chen, et al.. (2020). Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Neuro-Oncology Advances. 2(1). vdaa131–vdaa131. 13 indexed citations

13.

Voce, David J., Giovanna M. Bernal, Longtao Wu, et al.. (2019). Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma. Cancer Research. 79(10). 2536–2548. 78 indexed citations

14.

Wang, Sinan, Charles Blaha, Raquel Alves dos Santos, et al.. (2019). Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy. Molecular Pharmaceutics. 16(9). 3831–3841. 40 indexed citations

15.

Baal, Joe D., William Chen, David A. Solomon, et al.. (2019). Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes. American Journal of Neuroradiology. 40(3). 433–439. 7 indexed citations

16.

Han, Dae Yup, Lijun Ma, Steve Braunstein, et al.. (2018). Resection Cavity Contraction Effects in the Use of Radioactive Sources (1-25 versus Cs-131) for Intra-Operative Brain Implants. Cureus. 10(1). e2079–e2079. 14 indexed citations

17.

Raleigh, David R., et al.. (2015). Induction Hedgehog pathway inhibition followed by combined‐modality radiotherapy for basal cell carcinoma. British Journal of Dermatology. 173(2). 544–546. 21 indexed citations

18.

Crawley, Clayton D., David R. Raleigh, David J. Voce, et al.. (2012). DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site. Nucleic Acids Research. 41(2). 764–774. 20 indexed citations

19.

Yu, Dan, Amanda M. Marchiando, Christopher R. Weber, et al.. (2010). MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proceedings of the National Academy of Sciences. 107(18). 8237–8241. 203 indexed citations

20.

Raleigh, David R., Amanda M. Marchiando, Yong Zhang, et al.. (2010). Tight Junction–associated MARVEL Proteins MarvelD3, Tricellulin, and Occludin Have Distinct but Overlapping Functions. Molecular Biology of the Cell. 21(7). 1200–1213. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact